iNeo-Vac-R01 Clinical Trials
4 recruitingBiologic
Phase 14Phase 22
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
A Clinical Study on the Safety, Tolerability and Efficacy of Neoantigen-based Personalized mRNA Therapy iNeo-Vac-R01 Plus PD-1 Inhibitor in Adjuvant Treatment of Liver Cancer Post Radical Resection
Hepatocellular Carcinoma (HCC)
Yinghua Xu20 enrolled1 locationNCT07495215
Recruiting
Phase 1Phase 2
Evaluation of the Safety, Tolerability and Efficacy of iNeo-Vac-R01, an Individualized mRNA Therapeutic Technology Based on Tumor Neoantigens, for Adjuvant Treatment in Patients With Biliary Malignant Tumors After Radical Resection
Biliary Malignant Tumors
Yifan Wang20 enrolled1 locationNCT07368803
Recruiting
Phase 1
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms
Digestive System Neoplasms
Sir Run Run Shaw Hospital20 enrolled1 locationNCT06026800
Recruiting
Phase 1
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms
Digestive System Neoplasms
Sir Run Run Shaw Hospital20 enrolled1 locationNCT06019702